首页> 美国卫生研究院文献>International Journal of Nanomedicine >Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
【2h】

Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations

机译:聚乳酸-乙醇酸(PLGA)纳米粒传递给人胃癌细胞的布洛芬在极低的浓度下具有抗增殖活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeEpidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer cell line MKN-45. However, high doses of ibuprofen were required to elicit these antiproliferative effects in vitro. The present research compared the antiproliferative effects of ibuprofen delivered freely and released by poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) in MKN-45 cells.
机译:目的流行病学,临床和实验室研究表明,布洛芬是一种常用的非甾体类抗炎药,可抑制某些肿瘤的增殖和增殖。最近,我们证明了布洛芬对人胃癌细胞系MKN-45的抗增殖作用。但是,需要高剂量的布洛芬在体外引起这些抗增殖作用。本研究比较了布洛芬在MKN-45细胞中自由释放并由聚乳酸-乙醇酸(PLGA)纳米颗粒(NPs)释放的抗增殖作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号